Showing 1 - 20 results of 32 for search 'Hara, M', query time: 0.05s
Refine Results
-
1
Foreword to The Shame Game: Overturning the Toxic Poverty Narrative by O'Hara, M
Published 2020Book section -
2
-
3
-
4
Perspectives On Blood-Based Point-Of-Care Diagnostics by Quig K, Wheatley EG, O’Hara M
Published 2019-11-01
Article -
5
Reduction in laboratory turnaround time decreases emergency room length of stay by Kaushik N, Khangulov VS, O’Hara M, Arnaout R
Published 2018-04-01
Article -
6
-
7
Immunoregulatory T-cells can mediate specific unresponsiveness to alloantigens in vivo. by Wood, K, Hara, M, Kingsley, C, Karim, M, Bushell, A, Morris, P
Published 2001Journal article -
8
-
9
Beta-cell hubs maintain Ca2+ oscillations in human and mouse islet simulations by Lei, C, Kellard, J, Hara, M, Johnson, J, Rodriguez, B, Briant, L
Published 2018Journal article -
10
Flood insurance rate map for non-structural mitigation by Roslan Rasyikin, Omar Rohayu Che, Hara M., Solemon B., Baharuddin I.N.Z
Published 2019-01-01
Article -
11
-
12
CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection. by Jones, N, Van Maurik, A, Hara, M, Spriewald, B, Witzke, O, Morris, P, Wood, K
Published 2000Journal article -
13
CD40-CD40L independent activation of CD8+T cells can trigger allograft rejection. by Jones, N, Van Maurik, A, Hara, M, Spriewald, B, Witzke, O, Morris, P, Wood, K
Published 2000Journal article -
14
Spleen plays an important role in maintaining tolerance after removal of the vascularized heart graft. by Chosa, E, Hara, M, Watanabe, A, Matsuzaki, Y, Nakamura, K, Hamano, K, Wood, K, Onitsuka, T
Published 2007Journal article -
15
-
16
IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. by Hara, M, Kingsley, C, Niimi, M, Read, S, Turvey, SE, Bushell, A, Morris, P, Powrie, F, Wood, K
Published 2001Journal article -
17
Visualization of the in vivo generation of donor antigen-specific effector CD8+ T cells during mouse cardiac allograft rejection: in vivo effector CD8+ T cell generation during all... by Gilot, B, Hara, M, Jones, N, van Maurik, A, Niimi, M, Hadjianastassiou, V, Morris, P, Wood, K
Published 2000Journal article -
18
Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. by Jones, N, Turvey, SE, Van Maurik, A, Hara, M, Kingsley, C, Smith, C, Mellor, A, Morris, P, Wood, K
Published 2001Journal article -
19
Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells. by Niimi, M, Ikeda, Y, Shirasugi, N, Shatari, T, Takami, H, Kodaira, S, Matsumoto, K, Hamano, K, Esato, K, Hara, M, Wood, K
Published 2000Conference item -
20
Oral administration of alloantigen plus nondepleting anti-CD4 monoclonal antibody induces indefinite prolongation of fully allogeneic cardiac allografts. by Niimi, M, Ikeda, Y, Shirasugi, N, Shatari, T, Takami, H, Kodaira, S, Matsumoto, K, Hamano, K, Esato, K, Hara, M, Wood, K
Published 2000Conference item